The National Institute of Allergy and Infectious Diseases, which leads National Institutes of Health (NIH) efforts to provide proposal-writing resources, has posted four funded R21 proposals and accompanying summary statements online. These recent successful examples reflect the reduced NIH page limit. Each includes a one-page specific aims section, a 12-page research strategy, budget information, and biosketches of key personnel. While the proposals have an allergy/infectious disease research focus, they give researchers in all fields a view into excellent proposal development.
The NIH R21 mechanism supports early-stage project development for new exploratory and developmental research projects. R21 awards tend to support high-risk, high-reward research, with or without significant preliminary data, poised to produce innovations to substantially advance biomedical research. Awards are limited to $200,000 per year, up to $275,000 in direct costs over a project period of up to two years.
The NIH R21 mechanism supports early-stage project development for new exploratory and developmental research projects. R21 awards tend to support high-risk, high-reward research, with or without significant preliminary data, poised to produce innovations to substantially advance biomedical research. Awards are limited to $200,000 per year, up to $275,000 in direct costs over a project period of up to two years.
No comments:
Post a Comment